Andries M Bergman|Andries Bergman, Andre Bergman, Andre M Bergman

Andries M Bergman|Andries Bergman, Andre Bergman, Andre M Bergman

Netherlands Cancer Institute - Amsterdam / Netherlands
Others
AD Scientific Index ID: 4963233
Nederlands Kanker Instituut
person_outline Andries M Bergman|Andries Bergman, Andre Bergman, Andre M Bergman's MOST POPULAR ARTICLES
1-) Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a … ED Kwon, CG Drake, HI Scher, K Fizazi, A Bossi, AJM Van den Eertwegh, ... The lancet oncology 15 (7), 700-712, 2014 13782014
2-) Determinants of resistance to 2′, 2′-difluorodeoxycytidine (gemcitabine) AM Bergman, HM Pinedo, GJ Peters Drug resistance updates 5 (1), 19-33, 2002 3852002
3-) Basis for effective combination cancer chemotherapy with antimetabolitesGJ Peters, CL Van der Wilt, CJA Van Moorsel, JR Kroep, AM Bergman, ...Pharmacology & therapeutics 87 (2-3), 227-253, 20003742000
4-) Interaction between cisplatin and gemcitabine in vitro and in vivo.GJ Peters, AM Bergman, VW Ruiz van Haperen, G Veerman, CM Kuiper, ...Seminars in oncology 22 (4 Suppl 11), 72-79, 19953751995
5-) Synergistic interaction between cisplatin and gemcitabine in vitro.AM Bergman, VW Ruiz van Haperen, G Veerman, CM Kuiper, GJ PetersClinical cancer research: an official journal of the American Association …, 19963681996